InvestorsHub Logo
Followers 84
Posts 12471
Boards Moderated 0
Alias Born 07/25/2008

Re: None

Monday, 02/28/2022 6:08:19 AM

Monday, February 28, 2022 6:08:19 AM

Post# of 17452
$23.4 million in net revenue for the fourth quarter 2021 (60% increase from third quarter) and $45.6 million in net revenue for full year 2021

Company projects a net revenue guidance range of $115-$135 million from sales of LUPKYNIS™ (voclosporin) for 2022

Looks good!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News